u/CreativeLow3033

Hey everyone,

yesterday the Cochrane library posted a systematic review on Amyloid-beta-reduction therapy for Alzheimer’s and the results are that it has little to no effect. I was aware of the little effect based on CDR-SB score and all the stuff that was published when they got FDA/EMA approved. As somebody who treats these patients and uses this substances for a handful patients this is a rather shocking review and makes me wonder if FDA/EMA will take steps after this.

What is your opinion on this?

FYI I am a clinician on Europe